A sample report on
Nigeria Dialysis
Market
Includes Market Size, Market Segmented by Types
and Key Competitors (Data forecasts from 2022 – 2030F) www.insights10.com
This report presents a strategic analysis of the Nigeria Dialysis Market and a forecast for its development in the medium and long term. It provides a comprehensive overview of the market value, dynamics, segmentation, main players, growth and demand drivers, challenges & future outlook, etc.
This is one of the most comprehensive reports about the Nigeria Dialysis Market, and offers unmatched value, accuracy, and expert insights
Report Scope
Report Attribute
Details
Number of Pages
70-80
Base Year for Estimation
2022
Forecast Period
2023-2030
Market Overview, Revenue Forecast, Market Segmentation, Growth Factors and Trends, Report Coverage
Competitive Landscape, Key Company Profiles, Government Policies, Regulatory Landscape, Reimbursement Scenario
Quantitative Units
Revenue in USD Million/Billion (Mn/Bn)
Research Approach
Secondary Research (60%), Primary Research (40%)
Click on the icon to know the detailed methodology
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 3
Table of Content
CONTENT
PG. NO.
1. Nigeria Dialysis Overview
13-23
1.1. Overview
1.2. Nigeria Overview
1.3. Economic Overview: Nigeria
1.4. Dialysis Market in Nigeria
1.5. Healthcare Service Market in Nigeria
1.6. Healthcare Scenario in Nigeria
1.7. Health Insurance Coverage: Nigeria
1.8. Budget of the Government for Public Insurance
1.9. Mergers and Acquisitions
2. Market Size and Forecasting
24-29
2.1 Market size and forecasts (Excel and Methodology) A Sample Report on Nigeria Dialysis Market Analysis I Confidential 4
Table of Content
CONTENT
PG. NO.
2.2. Market Segmentation
2.2.1. By Product Type
2.2.2. By Application
2.2.3. By End Use
3. Market Dynamics
30-34
3.1. Market Growth Drivers
3.1.1. Growing Burden of Chronic Kidney Disease (CKD) 3.1.2. Increasing prevalence of Hypertension and Diabetes 3.1.3. Increasing Public Private Partnership
3.2. Market Restraints
3.2.1. Affordability and Financial Constraints
3.2.2. Lack of Skilled Healthcare Professionals
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 5
Table of Content
CONTENT
PG. NO.
3.2.3. Limited Awareness and Education
4. Competitive Landscape
35-44
4.1. Major Market Share
4.2. Key Company Profile
4.2.1. Fresenius Medical Care AG & Co. KGaA
4.2.1.1. Overview
4.2.1.2. Product Applications & Services
4.2.1.3. Recent Developments
4.2.1.4. Partnerships Ecosystem
4.2.1.5. Financials (Based on Availability)
4.2.2. JNC International
4.2.2.1. Overview
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 6
Table of Content
CONTENT
PG. NO.
4.2.2.2. Product Applications & Services
4.2.2.3. Recent Developments
4.2.2.4. Partnerships Ecosystem
4.2.2.5. Financials (Based on Availability)
4.2.3. Braun Melsungen AG
4.2.3.1. Overview
4.2.3.2. Product Applications & Services
4.2.3.3. Recent Developments
4.2.3.4. Partnerships Ecosystem
4.2.3.5. Financials (Based on Availability)
4.2.4. DaVita Inc
4.2.4.1. Overview
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 7
Table of Content
CONTENT
PG. NO.
4.2.4.2. Product Applications & Services
4.2.4.3. Recent Developments
4.2.4.4. Partnerships Ecosystem
4.2.4.5. Financials (Based on Availability)
4.2.5. Baxter International Inc.
4.2.5.1. Overview
4.2.5.2. Product Applications & Services
4.2.5.3. Recent Developments
4.2.5.4. Partnerships Ecosystem
4.2.5.5. Financials (Based on Availability)
4.2.6. NephroCare Nigeria
4.2.6.1. Overview
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 8
Table of Content
CONTENT
PG. NO.
4.2.6.2. Product Applications & Services
4.2.6.3. Recent Developments
4.2.6.4. Partnerships Ecosystem
4.2.6.5. Financials (Based on Availability)
4.2.7. Nipro Corporation
4.2.7.1. Overview
4.2.7.2. Product Applications & Services
4.2.7.3. Recent Developments
4.2.7.4. Partnerships Ecosystem
4.2.7.5. Financials (Based on Availability)
4.2.8. Kidney Clinics Nigeria
4.2.8.1. Overview
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 9
Table of Content
CONTENT
PG. NO.
4.2.8.2. Product Applications & Services
4.2.8.3. Recent Developments
4.2.8.4. Partnerships Ecosystem
4.2.8.5. Financials (Based on Availability)
4.2.9. Lagoon Hospitals Renal Dialysis Center
4.2.9.1. Overview
4.2.9.2. Product Applications & Services
4.2.9.3. Recent Developments
4.2.9.4. Partnerships Ecosystem
4.2.9.5. Financials (Based on Availability)
4.2.10. Kidney Clinics Nigeria Limited
4.2.10.1. Overview
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 10
Table of Content
CONTENT
PG. NO.
4.2.10.2. Product Applications & Services
4.2.10.3. Recent Developments
4.2.10.4. Partnerships Ecosystem
4.2.10.5. Financials (Based on Availability)
5. Reimbursement Scenario - Nigeria
45-48
5.1 Reimbursement Regulation by Nigerian Government
5.2 Reimbursement process for dialysis treatment in Nigeria 6. Methodology & Scope
49-54
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 11
Lifesciences Market
Research Reports you
can trust
Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
Nigeria Dialysis Market Analysis
1. Nigeria Dialysis Market Overview
1.1 Nigeria Overview
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
report
▪
In this section you will get an
understanding of the demographics of the
country/region, which includes the
213.4 Mn
$504 Bn
population, GDP, healthcare expenditure
and other details related to the topic
Is the total
Is the total Gross
population of Nigeria
domestic product
▪
In order to obtain access to all of the
(2021)
(GDP) of Nigeria
information that you are seeking, you will
(2022)
need to purchase the final report
▪
Final report will be comprehensive and
18.1 years
$2,326
detailed, and it will include data, analysis,
Is the median age
GDP per capita
trends, and other relevant information
in Nigeria (2021)
of Nigeria (2022)
related to the topic or subject matter of
interest
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 14
1.2 Economic Overview: Nigeria
Population of Nigeria, (2020-2030)
GDP of Nigeria, (2020-2030)
XX
XX
XX
XX
2020
2021
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
2020
2021
2022 2023F 2024F 2025F 2026F 2027F 2028F 2029F 2023F
Population Split (2023)
▪
In this section you will get an understanding of the demographics of the country/region, which includes the population, GDP, By Gender
By Age Group
healthcare expenditure and other details related to the topic
▪
In order to obtain access to all of the information that you are 0-14
seeking, you will need to purchase the final report
15-24
Female
Male
▪
Final report will be comprehensive and detailed, and it will 51%
49%
25-54
include data, analysis, trends, and other relevant information 55-64
related to the topic or subject matter of interest
65+
Illustrative
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 15
1.3 Statistics at a Glance: The Chronic Kidney Diseases (CKD) in Nigeria CKD Epidemiology in Nigeria
▪
Please be aware that this sample report
is intended to provide you with a brief
12%
14.1% and 9.5%
overview of the kind of information and
Is the overall
Is the prevalence of
analysis that will be presented in the
prevalence of CKD in
CKD in women and
final report
Nigeria
men respectively in
▪
In this section you will get an
Nigeria
understanding of the topic, which
includes the prevalence of the disease,
18%
11.7%
the application of medical devices, new
Is the prevalence of
Is the prevalence of
technology, and other details related to
CKD of in a rural
CKD in semi-urban
the topic in Nigeria
community in
South-Western
dwellers of South-
▪
In order to obtain access to all of the
Nigeria
East Nigeria
information that you are seeking, you
will need to purchase the final report
11.4%
26%
▪
Final report will be comprehensive and
Is the prevalence of
Is the prevalence of
detailed, and it will include data,
CKD in rural area of
CKD in North-West
analysis, trends, and other relevant
South-East Nigeria
Nigeria
information related to the topic or
subject matter of interest
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 16
1.3 Statistics at a Glance: The Chronic Kidney Diseases (CKD) in Nigeria (continued)
Current status of CKD and its service in Nigeria
▪
Please be aware that this sample report
▪
20 Mn Nigerians are living with CKD
is intended to provide you with a brief
▪
1% (200,000) of people living with CKD population are likely to progress to ESKD
overview of the kind of information and
analysis that will be presented in the
▪
2% (3000) of Nigerian ESKD patients were receiving hemodialysis in 2018; this final report
situation has not changed much in 2022
▪
In this section you will get an
understanding of the topic, which
▪
There are only 240 nephrologists, 697 registered dialysis nurses (145 of these includes the prevalence of the disease,
migrated to Western countries), and 120 dialysis technologists/technicians the application of medical devices, new
delivering care to the large population of CKD patients in Nigeria technology, and other details related to
the topic in Nigeria
Cost of Dialysis in Nigeria:
▪
In order to obtain access to all of the
information that you are seeking, you
▪
The financial cost of hemodialysis is still prohibitive for most Nigerians, considering will need to purchase the final report
the minimum wage of $72
▪
average cost of a session of hemodialysis is $96 compared with US$150 about 10
▪
Final report will be comprehensive and
years ago; and the cost is usually higher in private facilities detailed, and it will include data,
analysis, trends, and other relevant
▪
A tunnel catheter costs $192, temporary central catheter $60, and a femoral catheter information related to the topic or
$24, and AVF surgery costs $316–$722
subject matter of interest
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 17
1.4 Healthcare Services in Nigeria
Nigeria Healthcare Services Market Forecast, 2022-2030 (in $Bn) XX
XX
XX
XX
XX
XX
XX
XX
XX
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
▪
Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report
▪
In this section you will get an understanding of the overall healthcare services market in Nigeria, which includes the market size, current trends and other details related to the topic
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
Illustrative
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 18
1.5 Healthcare Scenario in Nigeria
▪
National Health Insurance Scheme (NHIS): A government implemented program aimed at providing affordable and accessible healthcare services to Nigerians, which helps to reduce out-of-pocket payments for healthcare and promotes financial risk protection
▪
Revitalization of Primary Healthcare Centers (PHCs): Nigerian government embarked on a program to revitalize PHCs across the country. This initiative includes improving infrastructure, staffing, and the availability of essential drugs at the primary healthcare level, which is crucial for delivering basic healthcare services to communities
▪
Disease Control Programs: Government has prioritized disease control programs to combat major public health issues. Programs targeting diseases like malaria, HIV/AIDS, tuberculosis, and vaccine-preventable diseases have been implemented, leading to improvements in disease management and prevention
▪
National Agency for Food and Drug Administration and Control (NAFDAC): NAFDAC is to regulate and control the manufacture, importation, exportation, distribution, advertisement, and use of food, drugs, cosmetics, medical devices, and chemicals. NAFDAC plays a crucial role in ensuring the safety, quality, and efficacy of healthcare products in Nigeria.
A few recent developments related to hemodialysis and peritoneal dialysis are mentioned below
▪
The Nigerian government signed into law the new National Health Insurance Act (NHIA) 2022
▪
NHIA replaces the National Health Insurance Scheme Act of 1999, which failed to enroll more than 10% of the population
May 2022
▪
NHIA seeks to promote, regulate and integrate health insurance schemes
▪
It aims to secure mandatory health insurance for every Nigerian and legal resident, and establishes a fund for the vulnerable groups, which will provide ‘subsidy for health insurance coverage for vulnerable persons and payment of health insurance premiums for indigents
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 19
1.5 Healthcare Scenario: Patient journey with Dialysis ongoing transplant management and care
Early Care and
Transition into Dialysis
Ongoing care coordination
Prevention
failed
unplanned
transplant
acute care
entry
episode
In-Center Dialysis
Primary care Clinician
Hospitalization
referral
modality
switch
Dialysis Facility
Transplant
•
Education
center
Hospital
•
Modality Selection
•
Insurance Initiation
Nephrologist
▪
Prevention and
assessment
management of CKD
for transplant
Vascular access
acute care
▪
Delay and prepare for
or peritoneal
Home Dialysis
planned
facility
episode
dialysis
Dialysis catheter
• Peritoneal Dialysis
entry
selection
placement
• Hemodialysis
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 20
1.6 Health Insurance Coverage: Nigeria
% of People by Type of Health Insurance Coverage
Number of People By Health Insurance Coverage
(2021)
Coverage Type
2020
2021
Change %
Uninsured
8.3
Total
327,521
328,074
With health insurance
91.7
Any health plan
299,230
300,887
0.4
Any private plan
217,896
216,366
–0.6
Any private plan
66.0
Employment-based
178,737
178,285
–0.2
Employment-based
54.3
Direct-purchase
10.2
Direct-purchase
33,869
33,555
–0.1
Marketplace
3.5
Marketplace coverage
10,924
11,389
0.1
TRICARE
2.5
TRICARE
9,165
8,299
–0.3
Any public plan
112,925
117,095
1.2
Any public plan
35.7
Medicare
58,541
60,226
0.5
Medicare
18.4
Medicaid
58,778
61,940
0.9
Medicaid
18.9
VA and CHAMPVA
2,967
3,151
0.1
VA and CHAMPVA
1.0
Uninsured
28,291
27,187
–0.4
▪
In 2021, most people (91.7%) had health insurance coverage at some point during 2021 and 8.3 % of people were uninsured for the entire calendar year
▪
More people had private health insurance (66%) than public coverage (35.7%)
▪
Employer-based insurance was the most common subtype of health insurance in the civilian, noninstitutionalized population (54.3%), followed by Medicaid (18.9%), Medicare (18.4%), direct-purchase insurance (10.2%), TRICARE (2.5%), and VA and CHAMPVA health care (1%)
Illustrative
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 21
1.8 Budget of Africa Government for Public Insurance Proposed Budget By Category
Outlays
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2022-31
Medicare
$769
$709
$766
$841
$840
$947
$1,014
$1,085
$1,227
$1,178
$1,325
$1,412
$10,633
In Billions Of Dollars
Medicaid
$458
$521
$571
$582
$616
$645
$674
$698
$734
$768
$801
$837
$6,926
Medicare
3.7%
3.2%
3.3%
3.4%
3.3%
3.6%
3.7%
3.8%
4.1%
3.8%
4.1%
4.2%
3.7%
As % Of GDP
Medicaid
2.2%
2.4%
2.4%
2.4%
2.4%
2.4%
2.4%
2.4%
2.5%
2.5%
2.5%
2.5%
2.4%
▪
National Health Expenditures (NHE) grew 2.7% to $4.3 trillion in 2021, or $12,914 per person, and accounted for 18.3% of Gross Domestic Product (GDP)
▪
Medicare spending grew 8.4% to $900.8 billion in 2021, or 21% of total NHE
▪
Medicaid spending grew 9.2% to $734.0 billion in 2021, or 17% of total NHE
▪
Private health insurance spending grew 5.8% to $1,211.4 billion in 2021, or 28% of total NHE
▪
Out of pocket spending grew 10.4% to $433.2 billion in 2021, or 10% of total NHE
▪
Other Third Party Payers and Programs and Public Health Activity spending declined 20.7% in 2021 to $596.6 billion, or 14% of total NHE
▪
Hospital expenditures grew 4.4% to $1,323.9 billion in 2021, slower than the 6.2% growth in 2020
▪
Physician and clinical services expenditures grew 5.6% to $864.6 billion in 2021, slower growth than the 6.6% in 2020
▪
Prescription drug spending increased 7.8% to $378.0 billion in 2021, faster than the 3.7% growth in 2020
▪
Largest shares of total health spending were sponsored by the federal government (34%) and the households (27%). The private business share of health spending accounted for 17% of total health care spending, state and local governments accounted for 15%, and other private revenues accounted for 7%
Illustrative
A Sample Report on Africa Dialysis Market Analysis I Confidential 22
1.9 Mergers and Acquisitions
RCM M&A Deal Value Trend ($Bn)
RCM M&A Deal Volume Trend
$16.7
112
107
107
110
89
$11.7
82
$10.5
$7.7
$6.8
$6.0
1H 2020
2H 2020
1H 2021
2H 2021
1H 2022
2H 2022
1H 2020
2H 2020
1H 2021
2H 2021
1H 2022
2H 2022
Buyer Composition: Strategic Vs Financial (2020)
Buyer Type by Deal Size
41%
41%
42%
39%
($Mn)
59%
59%
58%
61%
Strategic Buyers
Financial Buyers
$0- $25
$25-$50
$50-$100
$100+
57% of the total deal volume are done by strategic buyers and the rest 43% are done by financial buyers in 2020
Illustrative
A Sample Report on Africa Dialysis Market Analysis I Confidential 23
Nigeria Dialysis Market Analysis
2. Market Size and Forecasting
2.1 Market size and forecasts (Excel and Methodology) Click on the icon to know the
Nigeria Dialysis Market Forecast, 2022-2030 (in $Bn) methodology and assumption
▪
Please be aware that this sample report
XX
is intended to provide you with a brief
XX
overview of the kind of information and
analysis that will be presented in the
final report
▪
In this section you will get an
understanding of the overall Healthcare
Insurance market in Malaysia, which
includes the market size, current trends
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
and other details related to the topic
2023
2024
2025
2026
2027
2028
2029
2030
▪
In order to obtain access to all of the
Major Markets Patient
2.74
2.82
2.90
2.94
2.98
3.02
3.07
3.12
information that you are seeking, you
(Mn)
will need to purchase the final report
Nigeria Patient Size (Bn)
0.51
0.61
0.68
0.69
0.70
0.71
0.72
0.73
▪
Final report will be comprehensive and
% of US Patients
18.75% 21.70% 23.56% 23.45% 23.42% 23.39% 23.34% 23.45%
detailed, and it will include data,
analysis, trends, and other relevant
Global Market Size (Bn $)
3,620
3,780
3,950
4,128
4,314
4,508
4,711
4,937
information related to the topic or
subject matter of interest
Nigeria Market Size (Bn $)
61
74
84
87
91
95
99
106
Illustrative
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 25
2.2 Snapshot of Dialysis Market Segmentation
By Product Type
By Application
By End Use
Hemodialysis (HD)
In-Center Dialysis
Hemodialysis
Equipment
Settings
Peritoneal Dialysis
Contract Research
(PD) Equipment
Organizations
Home Care Settings
(CROs) Peritoneal
Concentrates and
Dialysis
Solutions
Catheters and
Tubings
Other Products
▪
In this section you will get an understanding of the segmentations which will cover the Nigeria Dialysis Market
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report A Sample Report on Nigeria Dialysis Market Analysis I Confidential 26
2.2.1 Market Segmentation: By Product Type
Nigeria Dialysis Market Share, By Product Type (2022)
▪
Hemodialysis market in Nigeria is a
significant component of the overall
dialysis treatment market
Other Products
▪
Please be aware that this sample report
is intended to provide you with a brief
Catheters and
Hemodialysis
Tubings
overview of the kind of information and
(HD) Equipment
analysis that will be presented in the
final report
▪
In order to obtain access to all of the
information that you are seeking, you
Concentrates
will need to purchase the final report
and Solutions
▪
Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
Peritoneal
subject matter of interest
Dialysis (PD)
Equipment
Illustrative
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 27
2.2.2 Market Segmentation: By Application Type
Nigeria Dialysis Market Share, By Application Type (2022)
▪
Hemolialysis market in Nigeria is a
significant component of the overall
cancer market
▪
Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the
final report
Contract
Research
Organizations
▪
In order to obtain access to all of the
(CROs)
information that you are seeking, you
Peritoneal
Hemodialysis
Dialysis
will need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data,
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
Illustrative
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 28
2.2.3 Market Segmentation: By End User
Nigeria Dialysis Market Share, By End User (2022)
▪
In-center dialysis settings have the
maximum market share in Nigeria
dialysis market with approximately xx%
▪
Please be aware that this sample report
is intended to provide you with a brief
overview of the kind of information and
Home Care
analysis that will be presented in the
Settings
final report
▪
In order to obtain access to all of the
information that you are seeking, you
will need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data,
In-Center
Dialysis Settings
analysis, trends, and other relevant
information related to the topic or
subject matter of interest
Illustrative
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 29
Nigeria Dialysis Market Analysis
3. Market Dynamics
3.1 Market growth drivers
3.1.1 In Nigeria crude prevalence of CKD was 14.7%, in the semiurban and rural populations the prevalence is 13.6%
and 16.9% respectively
▪
There is insufficient population-based data on CKD in Nigeria that is required to estimate its true burden, and to design prevention and Chronic Kidney Disease Burden in Nigeria
management strategies
▪
End-stage renal disease (ESRD) accounts for 8% of all medical admissions and 42% of renal admissions in Nigeria
▪
The prevalence of CKD in respondents 60 years and above was 27.8% in rural, 32.9% in semiurban and 30.4% in both communities combined
▪
Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
2010
2022
2030
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 31
3.1 Market growth drivers (continued)
Emergence of diabetes mellitus as an increasingly common cause has been documented in a study where diabetes mellitus constituted 28.4% of CKD cases
▪
Hypertension is a major cause of CKD and chronic renal failure (CRF) in Nigeria, in Enugu (South East) and Benin City (South South), Prevalence of Hypertension and Diabetes in
hypertension is the commonest cause of CKD and CRF
Nigeria
▪
It is only second to chronic glomerulonephritis in the South West, virtually all these reports are from urban settings
▪
Factors such as hypertension, diabetes, and lifestyle changes contribute to the increasing incidence of kidney diseases, creating a higher demand for dialysis services
▪
Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
2010
2022
2030
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 32
3.1 Market growth drivers (continued)
3.1.3 Despite its shortcomings, these data showed that Public Private Partnership (PPP) run renal center is reliable in terms of regular access to service delivery when compared to some government-operated hospitals
▪
Public-Private Partnerships: Collaboration between public and private entities in the healthcare sector drives the dialysis market
▪
Public-private partnerships enable the development of dialysis centers, procurement of equipment and supplies, capacity building, and the provision of affordable dialysis services to a larger population
▪
PPP has improved the availability of dialysis service, mean duration on dialysis, and mean number of dialysis sessions but did not improve the kidney transplant referral rate
▪
This is because it is free of the bureaucracy that characterizes public sector management with issues related to maintenance and supplies
▪
Please be aware that this sample report is intended to provide you with a brief overview of the kind of information and analysis that will be presented in the final report
▪
In order to obtain access to all of the information that you are seeking, you will need to purchase the final report
▪
Final report will be comprehensive and detailed, and it will include data, analysis, trends, and other relevant information related to the topic or subject matter of interest
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 33
3.2 Market restraints
3.2.1 Affordability is a
3.2.2 Lack of political
3.2.3 Lack of awareness about
significant restraint in
interference for kidney
kidney diseases, and available
the Nigeria dialysis
disease pretension and
treatment options restraining the
market
treatment
Nigeria dialysis market
▪
Financial cost of hemodialysis is still
▪
Government lacks the political will
▪
Awareness level of the Nigerian on
prohibitive for most Nigerians,
regarding improved care for ESKD
kidney functions and diseases was
considering the minimum wage of
patients, and this is despite
poor
US$72
advocacy efforts of nephrology
▪
60% of the Nigerian had a poor
▪
Average cost of a session of
associations and other
knowledge of kidney functions and
hemodialysis is US$96 compared
nongovernmental organizations
disease
with US$150 about 10 years ago;
▪
Unfortunately, accurate data on the
▪
Insufficient education and
and the cost is usually higher in
burden of ESKD in Nigeria are still
awareness campaigns among the
private facilities
lacking, and this crucial information
general population, healthcare
▪
Out-of-pocket payment is an
is needed for more effective
professionals, and policymakers can
enormous barrier to equitable
advocacy which will further
result in delayed diagnoses, late
dialysis access, which will hamper
restraining the dialysis market across
referrals to dialysis centers, and
the Nigeria dialysis market
the country
underutilization of dialysis services
Our analysis will thoroughly investigate the key restraints that may significantly impact business operations and growth.
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 34
Nigeria Dialysis Market Analysis
4. Competitive Landscape
4.1 Major Market Share
▪
Nigeria dialysis market is a highly
Revenue of Major players in Nigeria Dialysis Market ($ Mn) competitive space, with many companies
developing and marketing cancer
Company10
treatments
Company 9
▪
Some of the top companies in Nigeria
dialysis market based on revenue and
Company 8
market share include
Company 7
▪
In order to obtain access to all of the
information that you are seeking, you will
need to purchase the final report
Company 5
▪
Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
Company 3
related to the topic or subject matter of
interest
Company 2
Company 1
XX
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 36
4.2 Key Company Profile
Key Note:
1
Fresenius Medical Care AG &
▪
Here is the list of top 10 companies which
Co. KGaA
will cover in the final report
2
JNC International
▪
Each company will have slides for
o Overview
3
Braun Melsungen AG
o Key details
4
DaVita Inc
o Offerings
o Name of products
5
Baxter International Inc.
o Recent activities/ Press Coverage
o Distribution and Vendor Partners
6
NephroCare Nigeria
o Mergers, Acquisitions and
Collaboration
7
Nipro Corporation
o Financials
8
Kidney Clinics Nigeria
▪
If there are specific companies that you
would like to be included in the report,
please let us know via email
9
Lagoon Hospitals Renal
Dialysis Center
▪
In order to obtain access to all of the
Kidney Clinics Nigeria
information that you are seeking, you will
10
Limited
need to purchase the final report
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 37
4.2.1 JNC International
Company at Glance
Founded in: 1992
▪ JNC International are a leading Turnkey Medical Equipment
➢ Medical Equipment Distribution
Services and Solutions Company in Nigeria
HQ: Lagos, Nigeria
➢ Equpment Installation and Training
▪ JNC International focuses on distributing and supplying medical equipment, including dialysis machines, consumables, and related
➢ Equipment Maintenance and
Type: Private
supplies, to healthcare institutions and providers in Nigeria Support
▪ They work with hospitals, clinics, and other healthcare facilities to
➢ Equipment Maintenance and
Revenue: $XX Bn (2022)
ensure the availability of quality dialysis equipment and products Support:
▪ It’ expertise lies in sourcing and delivering advanced medical Website: www.jnciltd.com
➢ Healthcare IT Solutions
technologies from reputable global manufacturers
➢ Training and Capacity Building
JNC International Clients
Recent News/ Press Release
Lagos University Teaching Afe Babalola University
Aminu Kano University
▪
November 2022, JNCI Equips Kelina Hospitals,
Hospital, Lagos
Teaching Hospital
Teaching Hospital
Lagos, Kelina Hospitals officially opened its Lagos
branch
Ahmadu Bello University
National Orthopaedic
Euracare Multi-Specialist
Teaching Hospital
Hospitals
Hospital
▪
April 2022, Evidence supports Public Private
Reddington Hospital
Zaria - ABUTH
Lagoon Hospitals
Partnerships (PPP) as a strategy to improving
healthcare infrastructure and operations
Babcock University
▪
PPPs involve long term collaboration between the
Federal Medical Centres
Ibom Specialist Hospital
Teaching Hospital
public institutions and private sector participants
and are characterized by the sharing of risks,
Renal Pharmaceuticals
Renal Consulting Services
National Hospital
responsibilities and rewards between partners
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 38
4.2.1 JNC International (continued)
Latest Deals - Mergers and Acquisitions
Amount /
Company Name
Type
Year
Key Pointers
Duration
▪
Ivenix, Inc. announced that it has entered into a definitive agreement to be acquired by Fresenius Kabi, a global health care leader specializing in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition
March
▪
Ivenix’s advanced infusion system combined with Fresenius Kabi’s Acquisition
$240 Mn
2022
intravenous fluids and infusion therapy offerings will bring a comprehensive portfolio of infusion products to US
▪
Purchase price will be a combination of $240 Mn upfront payment Ivenix, Inc. acquired by
and milestone payments linked to achievements of commercial and Fresenius Kabi
operating targets
▪
ExThera Medical and Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, announced the expanded distribution of ExThera’s Partnership
-
Aug 2022
ExThera Medical
Seraph® 100 Microbind® Affinity Blood Filter in Mexico. In 2021, Agreement with
ExThera Medical and Fresenius Medical Care partnered to Fresenius Medical
distribute
Care
Illustrative
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 39
4.2.1 JNC International (continued)
Revenues ($Bn), 2020-2030
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
xx
xx
xx
report
▪
In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
2020
2021
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
availability
▪
In order to obtain access to all of the
Breakdown of Net Revenue by Segment, 2022
information that you are seeking, you will
need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
1
2
3
4
Illustrative
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 40
4.2.2 Company 2
Solutions offered by Company
Founded in:
HQ:
Type:
Revenue:
Website:
Drugs for Cancer
Recent Activity / Press Coverage
Drugs
Indications
Illustrative
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 41
4.2.2 Company 2 (continued)
Partnerships Ecosystem
Major Distribution Partners
Major Vendor Partners
Illustrative
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 42
4.2.2 Company 2 (continued)
Latest Deals - Mergers and Acquisitions
Amount /
Company Name
Type
Year
Key Pointers
Duration
Illustrative
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 43
4.2.2 Company 2 (continued)
Revenues ($Bn), 2020-2030
▪
Please be aware that this sample report is
intended to provide you with a brief
overview of the kind of information and
analysis that will be presented in the final
xx
xx
xx
report
▪
In this section you will the understating of
financial overview of the company, which
includes revenue forecasting, segment
revenue and other key details as per
2020
2021
2022
2023F
2024F
2025F
2026F
2027F
2028F
2029F
2030F
availability
▪
In order to obtain access to all of the
Breakdown of Net Revenue by Segment, 2022
information that you are seeking, you will
need to purchase the final report
▪
Final report will be comprehensive and
detailed, and it will include data, analysis,
trends, and other relevant information
related to the topic or subject matter of
interest
1
2
3
4
Illustrative
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 44
Nigeria Dialysis Market Analysis
5. Reimbursement Scenario - Nigeria
5.1 Reimbursement Regulation by Nigerian Government The Nigerian government, through the National Health Insurance Scheme (NHIS), provides health insurance coverage to eligible individuals. While the NHIS aims to improve access to healthcare services, including dialysis treatment, the specific reimbursement policies for dialysis treatment may vary. Here are some key points regarding dialysis treatment reimbursement by the government in Nigeria
National Health Insurance Scheme (NHIS):
▪
NHIS is a government agency responsible for implementing health insurance programs in Nigeria
▪
It offers various healthcare packages to different segments of the population, including formal sector employees, informal sector participants, and vulnerable groups
▪
Specific reimbursement policies for dialysis treatment are typically included in the benefit packages provided by the NHIS
Benefit Packages:
▪
NHIS offers different benefit packages with varying levels of coverage. Some of these benefit packages may include coverage for dialysis treatment, including the cost of dialysis sessions, medications, laboratory tests, and related services
▪
Coverage and reimbursement details can depend on the specific package and the contributions made by the enrollee Enrollee Contributions:
▪
Under the NHIS, enrollees are required to make regular contributions towards their health insurance coverage
▪
These contributions vary depending on the category of enrollment (e.g., formal sector, informal sector, vulnerable group)
▪
Reimbursement for dialysis treatment may be subject to the payment of appropriate premiums and compliance with NHIS guidelines A Sample Report on Nigeria Dialysis Market Analysis I Confidential 46
5.1 Reimbursement Regulation (continued)
Coverage Penetration (% Total Population)
Source of Funding
Spend on Healthcare (%of Current Health Expenditure) XX
XX
XX
XX
XX
Government Expenditure
xx
xx
xx
xx
xx
Public Healthcare
XX%
XX%
XX%
XX%
XX%
Private Health Insurance
Coverage
Out of Pocket
Private Coverage
9%
1%
6%
5%
5%
38.
37.
35.
32.
31.
Other
NA
NA
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
▪ Public insurance in Nigeria is primarily provided through NHS aims to provide affordable and accessible healthcare services to eligible individuals, including xx%
xx%
xx%
xx%
xx%
xx%
xx%
GDP Growth (yoy)
coverage for dialysis treatment, through various benefit packages
Private insurance plans may offer a range of coverage options, including dialysis xx%
xx%
xx%
xx%
xx%
NA
NA
HC Spend Growth (yoy)
treatment, but the coverage and reimbursement policies can vary depending on the specific plan and insurance provider.
Reimbursement Market Trends
▪ Reimbursement market trends in Nigeria indicate an increasing focus on expanding health insurance coverage and improving reimbursement processes for healthcare services, including dialysis treatment
▪ There is a growing recognition of the importance of sustainable reimbursement models to ensure equitable access to quality healthcare and incentivize healthcare providers to deliver efficient and effective services Illustrative
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 47
5.2 Reimbursement process for dialysis treatment in Nigeria Selection of
Enrollee
Treatment
Treatment
Claim
Claims Review &
Patient Co-
Healthcare
Registration
Authorization:
Delivery
Submission
Reimbursement
Payment
Provider
▪ Eligible
▪ Enrollees can
▪ Before initiating
▪ Once the
▪ Healthcare
▪ NHIS reviews
▪ Patients is
individuals need
choose a
dialysis
treatment
provider submits
the submitted
responsible for
to enroll in the
healthcare
treatment, the
authorization is
claims for
claims to ensure
co-payments or
NHIS or the
provider, such
healthcare
approved by the
reimbursement
they comply with
out-of-pocket
relevant
as a dialysis
provider submits
NHIS, the
to the NHIS on
the
expenses that
government
center or
a treatment
dialysis
behalf of the
reimbursement
are not covered
health insurance
hospital, that is
authorization
treatment is
enrolled patient
guidelines and
by the health
program
accredited and
request to the
initiated
▪ Claims include
policies
insurance
▪ This involves
recognized by
NHIS
according to the
details of the
▪ Claims are
program
completing the
the NHIS
▪ This request
prescribed plan
provided
evaluated for
▪ These costs can
necessary
▪ It's important to
includes relevant
▪ NHIS typically
services,
accuracy,
include
registration
select a provider
medical
covers a certain
treatment dates,
appropriateness
deductibles,
forms, providing
that offers
information,
number of
medications
of services, and
non-covered
required
dialysis services
prescribed
dialysis sessions
used, and any
adherence to
services, or
documentation,
and participates
treatment plan,
per month,
additional
treatment
additional
and paying the
in the NHIS
and estimated
depending on
necessary
protocols
charges beyond
appropriate
reimbursement
costs
the specific
documentation
the coverage
premiums or
program
benefit package
limits
contributions
and policy
A Sample Report on Nigeria Dialysis Market Analysis I Confidential 48
Nigeria Dialysis Market Analysis
6. Methodology & Scope
▪
Insights 10’s research methodology delves deeper into the market, covering the macro and micro aspects of the industry. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions
▪
We implement a mix of primary and secondary research for our market estimate and forecast. The secondary research forms the initial phase of our study where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources
▪
For forecasting, the following parameters are considered:
❑
Market drivers and restraints along with their current and expected impacts
❑
Technological scenario and expected developments
❑
End use industry trends and dynamics
❑
Trends in the consumer behavior
❑
Regulatory scenario and expected developments
❑
Current capacity and expected capacity additions up to 2030
▪
We assign weights to these parameters and quantify their market impacts using the weighted average analysis to derive the expected market growth rate
▪
We appoint data triangulation strategies to explore different areas of the market. Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions
▪
All our estimates and forecasts are verified through exhaustive primary research with the Key Industry Participants (KIPs)
▪
Currency used in the report is the US dollar (USD), with the market size indicated in USD million/billion (Mn/Bn)
Analysis Methodology
Our Analysis Methodology involves three critical stages: Data
Market Data Analysis
Interpretation &
Collection
& Statistical Model
Presentation
Secondary
Analysis &
Market Trends
Research
Interpretation
Primary
Market Sizing &
Insights
Research
Analysis
Proprietary
Data Triangulation &
Presentation &
Database
Validation
Reporting
Data Triangulation & Data Validation
Top Down Approach
Final
Final Market size break up to
Market
rest of segmentation
Size
Validation from
Arriving at market size
Primary Interview
of each segment
Summarization of revenue
generated from companies
Validation from
to arrive at total market size
Primary Interview
Revenue generated by products &
Final
services offered by companies
Summary
Bottom Up Approach
Key Benefits for Stakeholders from this Report Study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets
Our tools provides stakeholders with a cohesive understanding of the industry outlook, considering the qualitative and quantitative industry variables
Comprehensive analysis of factors that drive and restrict the market growth is provided Comprehensive quantitative analysis of the industry from 2022 to 2030F is provided to enable the stakeholders to capitalize on the prevailing market opportunities
Extensive analysis of the key segments of the industry helps understand the applications and technologies used globally Our rigorous data collection, thorough statistical analysis and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors
Time Frame
Report Attribute
Details
Quantitative Units
Revenue in USD Million/Billion (Mn/Bn)
Base Year for
2022
Estimation
Market Overview, Revenue Forecast, Market
Segmentation, Growth Factors and Trends,
Report Coverage
Company Profiles, Competitive Landscape,
Regulatory Landscape, Future Opportunities
Report Customization (3 to 5 working days)
with purchase. We will provide you with data
Customized Report
that is currently not a part of our scope as a
2023-
Forecast
part of customization
2030
Period
Pricing and purchase
Avail customized purchase options to meet
options
your exact research needs
A division of
Lifesciences Market
Research Reports you
can trust
Insights10 is a healthcare focused market
research firm founded with an aim of being an
insights driven company in the data driven world
and delivering actionable insights that can drive
decision and strategy making process for
businesses
Get actionable insights to
take informed business
decisions
A large database of over 30,000 syndicated
market research reports in Categoryname and
healthcare sector at global, regional as well as
country level. We also provide customized
research reports tailor made to suit your needs
Elevate your business plans
with in-depth market analysis
and industry intelligence
Our qualitative, acute, and result-oriented market
research reports provide a comprehensive
understanding of the business scenario and the
latest trends related to the life sciences market
Gain a competitive edge with
Insights10's customized
healthcare research solutions
Whether you are looking to expand into new
areas, develop new products, or take advantage
of new opportunities we have reports to help you
accelerate and improve your plans by identifying
unique growth prospects.
Market Research Reports
across various categories
Categoryname
Digital
Medical
Healthcare
OTC &
Clinical
(Diseases & Drugs)
Health
Devices
Services
Nutraceuticals
Trials
FEATURED REPORTS
FREE SAMPLE REPORTS
TRENDING TOPICS
What makes us different?
30000+
22000+
2000+
1200+
Life science
Country
Rare & orphan
Reports
Market Research
Specific
Disease
Published
Reports
Reports
Reports
Annually
Table of Contents
Market Overview
Competitive Landscape
1
6
Growth Drivers &
Key Company Profiles
2
7
Growth Restraints
Epidemiology &
Policy & Regulatory
3
8
Disease type
Landscape
insights on
which our
reports are
Market Segmentation
based
4
9
Reimbursement Scenario
Market Share
5
10
Factors Driving Future Growth
Our Services
Market Research
Customized
Primary
Reports
Reports
Research
Database
Full-Time
Conference
Service
Engagement
Coverage
Competitive
Regulatory
Subscription
Intelligence
Compliance
Over the years, we have developed an in-depth experience of executing market analysis at global, regional & country specific level in life sciences.
Our team has
conducted market
research across 62+
global markets in
America, Europe,
Middle East, Nigeria
and Asia Pacific regions
Research Projects Done
Our Research Process
01
02
03
04
05
Identification of
Market
Collection of
Collaboration
Verification &
Data
Dynamics
Data
of Data
Analysis
Statistical Databases
Company Websites/Annual Reports
Data
Sources
Trade Publications
We have access to multiple highly
Online Databases
reliable free and subscription data
sources. We have many years of
experience to understand which
Published Research Reports
sources are more dependable for what
and which to prefer for the reliable and
Whitepapers
latest information.
Press Releases of Key Market Players
What kind of data is presented
in our reports?
Our reports present data, which is:
Reliable
Expert-verified
Real
Comprehensive
Easy to read
The report is
The data is prepared
Allowing you to
Covers everything
You do not have to
prepared using a
by a team of highly
confidently make
you would need to
be a market expert
proven methodology
qualified &
smarter business
know about the
to understand what
and insightful
experienced research
and strategic
market including
really is happening
research
analysts & vetted by
decisions
market size,
on the market and
our local associates
competitive analysis
how it works
& much more
The team
“The business decision-making process is no longer as straightforward as it used to be. It requires insights generated at the right time, based on reliable data interpreted in a nuanced manner for each market.
We at Insights10 are building the future of market research and are committed to providing our clients with the right intelligence and insights to make business decisions quickly and efficiently.
Insighs10 is a unique platform that combines deep domain expertise, nuanced data at a country and
functional area level, and years of experience working with some of the best organizations in the world, generating insights that provides substantial competitive advantage.”
Dr. Purav Gandhi
Founder & CEO
Leadership Team
Dr. Purav Gandhi
Anish Swaminathan
Mukesh Nayak
Ritu Baliya
Founder & CEO
Director
Head – Marketing & Research
Engagement Manager
Purav is a physician and an entrepreneur
Anish has 15+ years of experience
Mukesh is an engineering graduate with
Ritu has over 6 years of experience in
with 12+ years of experience in Healthcare
in management consulting in the
an MBA in Marketing. He is a seasoned
strategy building, market assessments,
& Life Sciences industry spanning across
Life Sciences sector, and has
healthcare market research & marketing
market sizing, and RWE for global MNC
strategy, market access, health informatics
worked with diverse multinational
professional with a progressive
healthcare & biopharma clients across diff.
and RWE, digital health, analytics and data
firms in the US, India, Middle East
experience of over 20 years in Life
markets (America, Europe, Nigeria, APAC
science. Purav studied medicine from
and APAC regions. His primary
Sciences, Pharma and Medical Device
and Middle East). Her areas of expertise
Gujarat University and also completed his
area of interest is Customer and
sectors. With an in-depth understanding
include: Indentifying emerging trends in life
MBA from IIM-Kozhikode. Purav started
Market Strategy, Market Access,
of primary research, he has conducted
sciences industry, Competitor landscape
his career with Deloitte working on strategy
and Digital Health with special
hundreds of interviews of various
assessment, Disease opportunity
consulting engagements and also co-
focus on emerging markets like
stakeholders in pharma & healthcare &
assessments etc. She is a pro in secondary
founded ConvergeHealth by Deloitte.
Nigeria, Middle East and APAC.
completed several research projects
and primary research with a deep domain
across life sciences industry.
expertise in healthcare sector.
Our Team
Our Clients
Our Clients
… and many more
Do you have
any questions?
We would be happy to help.
Web: www.insights10.com
Email: insights@insights10.com
Call: (+91) 931 639 7935
WhatsApp: (+91) 931 639 7935
Thank you
We truly appreciate your business and
look forward to serving you.
www.insights10.com
